| Trial ID: | L2508 |
| Source ID: | NCT06473662
|
| Associated Drug: |
Oral Insulin
|
| Title: |
Study to Evaluate the Safety and Efficacy of Oral Insulin Formulation in Type 2 Diabetes Mellitus Subjects
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT06473662/results
|
| Conditions: |
Type 2 Diabetes Treated With Insulin
|
| Interventions: |
DRUG: Oral insulin
|
| Outcome Measures: |
Primary: Change in HbA1c, Change in HbA1c Relative to Baseline at Start of Study, 12 weeks | Secondary: Change in Fasting Plasma Glucose, Change in Fasting Plasma Glucose Relative to Baseline at Start of Study, 12 weeks|Change in Post-Prandial Glucose, Change in Post-Prandial Glucose Relative to Baseline at Start of study, 12 weeks|Changes in Triglycerides, Change in Triglycerides Relative to Baseline at Start of Study, 12 weeks
|
| Sponsor/Collaborators: |
Sponsor: Roger New
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
153
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2018-10-22
|
| Completion Date: |
2020-07-11
|
| Results First Posted: |
2025-02-06
|
| Last Update Posted: |
2025-02-06
|
| Locations: |
Diabetology, London, NW1 0NH, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT06473662
|
